Literature DB >> 14992742

Effects of transurethral resection of prostate on the quality of life of patients with benign prostatic hyperplasia.

MartinJ O'Sullivan1, Colette Murphy, Conor Deasy, Gabrielle Iohom, Eamon A Kiely, George Shorten.   

Abstract

BACKGROUND: This article investigated the effects of transurethral resection of prostate on quality of life (QOL) and urinary symptoms in patients with benign prostatic hyperplasia (BPH). STUDY
DESIGN: In a prospective study, 30 patients without significant comorbidities undergoing transurethral resection of prostate for BPH were studied. Patients completed four validated questionnaires: the International Prostate Symptom Score and the associated QOL index because urinary symptoms, the Montgomery and Asberg Depression Rating Scale, the McGill Pain Questionnaire, and the QOL questionnaire Short Form-36. These were completed preoperatively, on the first postoperative day, on discharge from hospital, and at 1 and 3 months postoperatively.
RESULTS: The QOL of patients who undergo transurethral resection of prostate for BPH had significantly improved at 3 months after their operation. The International Prostate Symptom Score scores at 1 month (9.3+/-4.6) and 3 months (5.4+/-5.6) were less than they were preoperatively (19.9+/-7.1). The QOL index because urinary symptoms was less at 1 month (2.4+/-1.9) and at 3 months postoperatively (1.5+/-1.4) in comparison with the preoperative scores (4.5+/-1.2). The Montgomery and Asberg Depression Rating Scale scores at 1 month (5.4+/-6.8) and 3 months (4.9+/-6.5) were less than they were preoperatively (9.2+/-8.3). The McGill Pain Questionnaire sensory and pain rating index scores were less at 3 months than they were preoperatively (p=0.02 and p<0.02 respectively). The McGill Pain Questionnaire affective score was less at 1 month than it was preoperatively (p<0.03). The McGill Pain Questionnaire evaluative scores were less than the preoperative score at all times postoperatively. The role physical (p=0.007), bodily pain (p=0.006), social function (p=0.007), and physical component summary (p=0.007) subsections of the Short Form-36 were greater at 3 months postoperatively when compared with the preoperative scores.
CONCLUSIONS: Transurethral resection of prostate is associated with significant improvement in the overall QOL, in addition to urinary symptoms, of patients with BPH at 3 months postoperatively. The magnitude and timing of this improvement may serve as a useful comparator in determining the optimal treatment of patients with BPH.

Entities:  

Mesh:

Year:  2004        PMID: 14992742     DOI: 10.1016/j.jamcollsurg.2003.10.016

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  6 in total

Review 1.  Models of inflammation of the lower urinary tract.

Authors:  Dale E Bjorling; Zun-Yi Wang; Wade Bushman
Journal:  Neurourol Urodyn       Date:  2011-06       Impact factor: 2.696

2.  Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy.

Authors:  Dionisios Mitropoulos; Stefanos Papadoukakis; Anastasios Zervas; Christos Alamanis; Aris Giannopoulos
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  Superselective α-adrenergic blockers versus transurethral resection of the prostate: a prospective comparison of health-related quality of life outcome after treating patients with benign prostatic hyperplasia.

Authors:  Negin Hadi; Alireza Aminsharifi; Ali Sadeghi; Ali Tourchi
Journal:  Qual Life Res       Date:  2012-09-05       Impact factor: 4.147

4.  A possible mechanism underlying mood disorders associated with LUTS: Chronic bladder outlet obstruction causes NLRP3-dependent inflammation in the hippocampus and depressive behavior in rats.

Authors:  Francis M Hughes; Nathan A Hirshman; Hamza A Malick; Simon W White; Huixia Jin; Shelby N Harper; J Todd Purves
Journal:  Neurourol Urodyn       Date:  2020-06-29       Impact factor: 2.696

5.  Depressive symptoms in patients diagnosed with benign prostatic hyperplasia.

Authors:  Barbara Pietrzyk; Magdalena Olszanecka-Glinianowicz; Aleksander Owczarek; Tomasz Gabryelewicz; Agnieszka Almgren-Rachtan; Andrzej Prajsner; Jerzy Chudek
Journal:  Int Urol Nephrol       Date:  2015-02-12       Impact factor: 2.370

6.  The predictive role of toll-like receptor-4 genetic polymorphisms in susceptibility to and prognosis of prostatic hyperplasia.

Authors:  Yunhua Qiu; Jinzhou Zheng; Jianfeng Yang; Feng Li; Xiqiu Zhou; Xiaoyun Song
Journal:  Iran J Basic Med Sci       Date:  2019-01       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.